Healthcare provider profile · identity verified

Amanda Brenner, MD

Family Practice · JACKSONVILLE, FL · NPI 1104445113

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	376	118
Metoprolol Tartrate	Metoprolol Tartrate	268	51
Gabapentin	Gabapentin	220	60
Amlodipine Besylate	Amlodipine Besylate	212	65
Furosemide	Furosemide	209	64
Eliquis	Apixaban	190	58
Pantoprazole Sodium	Pantoprazole Sodium	149	54
Levothyroxine Sodium	Levothyroxine Sodium	143	57
Potassium Chloride	Potassium Chloride	136	40
Lisinopril	Lisinopril	132	37
Carvedilol	Carvedilol	130	38
Tamsulosin Hcl	Tamsulosin Hcl	128	39
Clopidogrel	Clopidogrel Bisulfate	125	29
Losartan Potassium	Losartan Potassium	110	35
Mirtazapine	Mirtazapine	97	25
Trazodone Hcl	Trazodone Hcl	94	32
Myrbetriq	Mirabegron	92	suppressed
Donepezil Hcl	Donepezil Hcl	83	21
Memantine Hcl	Memantine Hcl	82	20
Duloxetine Hcl	Duloxetine Hcl	81	18
Buspirone Hcl	Buspirone Hcl	80	18
Sertraline Hcl	Sertraline Hcl	75	28
Levetiracetam	Levetiracetam	74	11
Omeprazole	Omeprazole	72	21
Tradjenta	Linagliptin	72	suppressed
Amiodarone Hcl	Amiodarone Hcl	65	15
Hydralazine Hcl	Hydralazine Hcl	63	35
Spironolactone	Spironolactone	63	18
Ondansetron Hcl	Ondansetron Hcl	62	29
Escitalopram Oxalate	Escitalopram Oxalate	59	13
Famotidine	Famotidine	59	26
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	58	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	12
Diclofenac Sodium	Diclofenac Sodium	54	20
Fluticasone Propionate	Fluticasone Propionate	53	19
Nuplazid	Pimavanserin Tartrate	48	suppressed
Metoprolol Succinate	Metoprolol Succinate	47	25
Montelukast Sodium	Montelukast Sodium	47	13
Bumetanide	Bumetanide	42	13
Quetiapine Fumarate	Quetiapine Fumarate	42	17
Ropinirole Hcl	Ropinirole Hcl	41	12
Lactulose	Lactulose	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	12
Insulin Lispro Kwikpen U-100	Insulin Lispro	36	14
Nystatin	Nystatin	36	14
Rosuvastatin Calcium	Rosuvastatin Calcium	36	15
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Metformin Hcl	Metformin Hcl	35	24
Finasteride	Finasteride	34	11
Latanoprost	Latanoprost	34	11
Novolog Flexpen	Insulin Aspart	34	11
Allopurinol	Allopurinol	33	14
Insulin Aspart Flexpen	Insulin Aspart	32	suppressed
Nifedipine Er	Nifedipine	30	14
Sodium Chloride	0.9 % Sodium Chloride	30	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	16
Torsemide	Torsemide	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Midodrine Hcl	Midodrine Hcl	25	15
Alendronate Sodium	Alendronate Sodium	24	suppressed
Ceftriaxone	Ceftriaxone Sodium	24	15
Dapagliflozin	Dapagliflozin Propanediol	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	11
Prednisone	Prednisone	24	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	13
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Simvastatin	Simvastatin	22	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	14
Baclofen	Baclofen	21	12
Doxepin Hcl	Doxepin Hcl	21	suppressed
Ammonium Lactate	Ammonium Lactate	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	20	suppressed
Levofloxacin	Levofloxacin	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	14
Divalproex Sodium	Divalproex Sodium	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Methocarbamol	Methocarbamol	18	13
Olanzapine	Olanzapine	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	13
Cephalexin	Cephalexin	17	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	12
Hydrocortisone	Hydrocortisone	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Primidone	Primidone	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Levobunolol Hcl	Levobunolol Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Atenolol	Atenolol	14	suppressed
Lidocaine Hcl	Lidocaine Hcl	14	11
Ranolazine Er	Ranolazine	14	suppressed
Restasis	Cyclosporine	14	suppressed
Roflumilast	Roflumilast	14	suppressed
Topiramate	Topiramate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Vancomycin Hcl	Vancomycin Hcl	14	12
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Budesonide	Budesonide	13	11
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	13	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	12	12
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	11
Azelastine Hcl	Azelastine Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error